Navigation Links
ECC Signs a Contract for the Finance, Design, and Construction of a Premier Cancer Institute in Ibadan, Nigeria
Date:7/24/2014

BURLINGAME, Calif., July 24, 2014 /PRNewswire/ -- ECC West Africa, LLC (ECC) signed a contract in Denver, Colorado with University College Hospital (UCH) Ibadan Board of Management for the first phase of a development project to finance, design, construct, and operate and maintain a new, state-of-the-art Cancer Institute in Ibadan, Nigeria. Under the first of the 4-phase project, ECC will conduct feasibility studies and prepare scoping documents and funding applications. UCH Ibadan intends to finance and develop the Cancer Institute using funding from Export-Import Bank and other financial institutions.

The Cancer Institute will be an innovative, holistic diagnostic center, including oncological screening, diagnosis, treatment, prevention, training, and research.

"Medical infrastructure and accessibility are critical steps in leading the fight against disease throughout Africa," comments ECC's President & CEO, Manjiv S. Vohra, PE, DBIA.  "UCH Ibadan and its new Cancer Institute will provide premier oncological services, touching the lives of millions of people and their families affected by cancer. We are proud to lead the development of this ground-breaking institution."

Professor Temitope Oluwagbenga Alonge, MBBS Ibadan, MD Leicester, FRCS Edinburgh, FWACS, UCH Ibadan Chief Medical Director, represented the Board of Management during the signing. He stated, "Cancer is a leading cause of death at UCH Ibadan. Accurate diagnosis of cancer is germane to targeted treatment modalities. Our partnership with ECC, a world-class, renowned, and reputable company, will no doubt ensure a more accurate diagnosis, and by extension, appropriate and targeted treatment of cancers, as well as offer opportunities for cutting-edge research and the development of protocols in UCH, Nigeria, and the West African sub-region."

ECC teamed with strategic partners General Electric Healthcare and Health Technologies International to develop the Cancer Institute. Additionally, a major component of the project involves building capacity of the local workforce. "ECC invests heavily in building relationships with local Nigerian partners who will play a pivotal role in the development of the Cancer Institute," stated Mr. Vohra.

The UCH Ibadan Cancer Institute is estimated to be completed within 2 years.

About UCH Ibadan: Established by an act of parliament in November 1952, UCH Ibadan is the leading teaching hospital and tertiary healthcare provider in Nigeria. UCH Ibadan provides excellent healthcare training, cutting-edge research, and unparalleled healthcare services to Nigerians and citizens of neighboring West African States. Its Accident and Emergency Department averages 6,000 new patients annually, and its clinics serve 150,000 new patients each year. uch-ibadan.org.ng

About ECC: Established in 1985, ECC is an employee-owned company that provides a complete range of services to support its clients' missions, including design-build, construction, environmental remediation, energy, munitions response, and international development. ECC serves the U.S. Agency for International Development; U.S. Departments of Defense, Energy, and State; and other international agencies.  www.ecc.net


'/>"/>
SOURCE ECC
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. Bacterin Signs Distribution Agreement with Jeil for LeForte Craniomaxillofacial System
2. Roche Signs Agreement with PTC Therapeutics to Advance Treatment for Spinal Muscular Atrophy (SMA)
3. BioRestorative Therapies Signs Material Manufacturing Agreement With University of Utah
4. The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
5. Metamark Genetics Signs Collaboration Agreement on Novel Therapeutic Targets with Janssen Biotech
6. Agendia Signs Contract with Blue Shield of California
7. New England Biolabs Signs Agreement with Synthetic Genomics Inc. to Launch Gibson Assembly™ Master Mix for Molecular and Synthetic Biology Applications
8. Volition Signs Collaboration Agreement With Abcodia
9. MiMedx Signs Agreement with Systagenix for Global Distribution of EpiFix®
10. Psyche Systems Corporation Signs Strategic Alliance with Siemens Healthcare to Provide Anatomic Pathology Solutions
11. IntelliCell BioSciences Signs Technology Licensing Agreement with Stem Cells 21 Thailand
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 A person commits a ... crime scene to track the criminal down. An ... Food and Drug Administration (FDA) uses DNA evidence to track ... Sound far-fetched? It,s not. The FDA has increasingly ... support investigations of foodborne illnesses. Put as simply as possible, ...
(Date:6/23/2016)... MA (PRWEB) , ... June 23, 2016 , ... ... Peel Plate® YM (Yeast and Mold) microbial test has received AOAC Research Institute ... platform of microbial tests introduced last year,” stated Bob Salter, Vice President of ...
(Date:6/23/2016)... 23, 2016  The Biodesign Challenge (BDC), a university ... to harness living systems and biotechnology, announced its winning ... New York City . ... showcased projects at MoMA,s Celeste Bartos Theater during the ... MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... announced the launch of the Supplyframe Design Lab . Located in Pasadena, ... explore the future of how hardware projects are designed, built and brought to ...
Breaking Biology Technology:
(Date:4/15/2016)... 15, 2016  A new partnership announced today ... underwriting decisions in a fraction of the time ... and high-value life insurance policies to consumers without ... With Force Diagnostics, rapid testing (A1C, Cotinine and ... (blood pressure, weight, pulse, BMI, and activity data) ...
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
(Date:3/31/2016)... March 31, 2016   ... or the "Company") LegacyXChange is excited to ... its soon to be launched online site for trading ... ) will also provide potential shareholders a sense ... technology to an industry that is notorious for fraud. ...
Breaking Biology News(10 mins):